Premium
O4‐08‐05: Azeliragon Phase 2B Survival Analysis Supports Beneficial Effects on Delaying Time to Cognitive Deterioration in Patients with Mild Alzheimer's Disease
Author(s) -
Burstein Aaron H.,
Dunn Imogene,
Soeder Tom,
Sabbagh Marwan N.,
Altstiel Larry D.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.653
Subject(s) - placebo , medicine , memantine , post hoc analysis , gastroenterology , subgroup analysis , disease , dementia , confidence interval , pathology , alternative medicine